Login to Your Account



Financings Roundup

Ambit's Series D Raises $50M For Kinase Inhibitor Program

By Trista Morrison


Wednesday, November 14, 2007
With one kinase inhibitor in the clinic and two more in the queue, Ambit Biosciences Corp. raised $49.3 million in a Series D financing round. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription